Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Lunfei LIU"'
Publikováno v:
Indian Journal of Dermatology, Vol 68, Iss 1, Pp 59-66 (2023)
Psoriasis is a chronic inflammatory disease that is considered by a network of immunocytes and cytokines. Among all, Th17 cells–derived IL-17 is a critical driving factor in the pathogenesis of psoriasis. Recently, disruption of the extracellular m
Externí odkaz:
https://doaj.org/article/8c31040d9bca4e95b37b7f1ddb95cc5c
Genome-wide association analysis of anti-TNF-α treatment response in Chinese patients with psoriasis
Autor:
Yunqing Ren, Ling Wang, Huatuo Dai, Guiying Qiu, Jipeng Liu, Dianhe Yu, Jianjun Liu, Cheng-Zhi Lyu, Lunfei Liu, Min Zheng
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: TNF-α inhibitors are effective biological agents for treating psoriasis, but the treatment responses differ across patients. This study aimed to identify genetic biomarkers of anti-TNF-α response in Chinese psoriasis patients using a ge
Externí odkaz:
https://doaj.org/article/fb3c1ded13c9458d9038698820bbdb65
Autor:
Lunfei Liu, Jisu Chen, Jinhua Xu, Qinping Yang, Chaoying Gu, Chunya Ni, Linfeng Li, Xueyan Lu, Zhirong Yao, Jianfeng Tao, Yifeng Guo, Hong Fang, Yingguo Ding, Qihong Qian, Naihui Zhou, Miaomiao Wang, Danqi Deng, Hong Xie, Shenqiu Li, Yongchu Huang, Naiqing Zhao, Min Zheng
Publikováno v:
Artificial Cells, Nanomedicine, and Biotechnology, Vol 47, Iss 1, Pp 3540-3547 (2019)
Allergen-specific immunotherapy is widely used for allergic rhinitis and asthma treatment worldwide. This study explored the efficacy and safety of sublingual immunotherapy (SLIT) with the extracts of Dermatophagoides Farinae (D. farinae Drops) on ho
Externí odkaz:
https://doaj.org/article/5cf3b81553a84a14ac143d0d08a639e8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of clinical pharmacy and therapeuticsREFERENCES. 46(3)
The dosages of valaciclovir used for herpes zoster treatment recommended by Chinese pharmaceutical companies can differ considerably from those reported in the literature. This randomized clinical study compares the efficacy and safety of different o
Autor:
Danqi Deng, Qinping Yang, Chunya Ni, Hong Xie, Naiqing Zhao, Linfeng Li, Qihong Qian, Shenqiu Li, Chaoying Gu, Min Zheng, Jianfeng Tao, Zhirong Yao, Lunfei Liu, Hong Fang, Naihui Zhou, Miaomiao Wang, Yingguo Ding, Yifeng Guo, Ji-Su Chen, Jinhua Xu, Yongchu Huang, Xueyan Lu
Publikováno v:
Artificial cells, nanomedicine, and biotechnology. 47(1)
Allergen-specific immunotherapy is widely used for allergic rhinitis and asthma treatment worldwide. This study explored the efficacy and safety of sublingual immunotherapy (SLIT) with the extracts...
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2019 (2019)
BioMed Research International, Vol 2019 (2019)
Objective.This phase I study aimed to systematically assess the safety, local tolerability, pharmacokinetics, and preliminary efficacy of topical icotinib hydrochloride cream in patients with mild to moderate plaque psoriasis.Materials and Methods.El
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Volume: 54, Issue: 4, Article number: e17349, Published: 08 APR 2019
Brazilian Journal of Pharmaceutical Sciences, Vol 54, Iss 4 (2019)
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e17349
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17349
Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17349
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 54, Iss 4 (2019)
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e17349
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17349
Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17349
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Psoriasis is a T-cell mediated disease that involves IL-23/Th17 and IL-12/Th1 axes. Ustekinumab, a fully human monoclonal antibody targeting the p40 subunit of both IL-12 and IL-23, has proven to be efficient and safe for treating patients with psori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ab83c55d1c6f7ff4684d0fc7393b6cd
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000400615&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000400615&lng=en&tlng=en
Autor:
Min Zheng, Jiong Zhou, Lunfei Liu, Yunqing Ren, Jianjun Liu, Yu-Xin Zheng, Huatuo Dai, Sui-Qing Cai, Wenting Liu, Ji-Su Chen
Publikováno v:
BMC Systems Biology
BMC Systems Biology, Vol 13, Iss S2, Pp 1-9 (2019)
BMC Systems Biology, Vol 13, Iss S2, Pp 1-9 (2019)
Background Anti-tumor necrosis factor alpha (TNF- α) therapy has made a significant impact on treating psoriasis. Despite these agents being designed to block TNF- α activity, their mechanism of action in the remission of psoriasis is still not ful
Autor:
Lunfei LIU, Chunlei ZHANG, Jinyan WANG, Kun CHEN, Yangfeng DING, Guofu YAN, Qianjin LU, Wei LI, Hong FANG, Hao CHENG, Jianzhong ZHANG, Yanling HE, Wei ZHU, Yan LU, Jinhua HUANG, Weili PAN, Ming LI, Shuanglin CAO, Shanshan LI, Xiuping HAN
Publikováno v:
European Journal of Dermatology; sep/Oct2020, Vol. 30 Issue 5, p580-590, 11p